Literature DB >> 28735371

Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).

Lori Wiener1, Haven Battles2, Sima Zadeh Bedoya2, Andrea Baldwin2, Brigitte C Widemann2, Maryland Pao3.   

Abstract

Children and adolescents with Neurofibromatosis type 1 (NF1) are at increased risk for wide-ranging behavioral, developmental, and cognitive impairments and decreased quality of life. To date, no psychosocial screening tool has been developed to quickly assess the symptoms that 1) can be addressed during routine medical appointments in children with NF1, 2) can produce interpretable and actionable results, 3) can be integrated into medical care, and 4) can quickly identify patients at risk in order to better address that the provision of appropriate care are available. This study was conducted to test the overall usability of the Distress Thermometer (DT) and symptom checklist and concordance of DT ratings between pediatric patients, their caregivers and medical providers. Eighty youth (ages 7-21) living with NF1 completed the DT and an accompanying checklist. The findings of this study suggest the DT and symptom checklist was acceptable and feasible to complete in a clinic setting. A small subset reported high distress that required further assessment and intervention. Significant discordance between distress ratings of caregivers and children and healthcare providers was also found. Overall, the DT and accompanying symptom checklist provide important information to identify the presence of distress and contextualize the child's distress but is limited by not assessing whether these symptoms interfere with the child's daily life.

Entities:  

Keywords:  Neurofibromatosis-1; Pediatric distress screening; Psychosocial assessment

Mesh:

Year:  2017        PMID: 28735371      PMCID: PMC6287491          DOI: 10.1007/s10897-017-0128-1

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  47 in total

1.  Issues in the design of Internet-based systems for collecting patient-reported outcomes.

Authors:  James B Jones; Claire F Snyder; Albert W Wu
Journal:  Qual Life Res       Date:  2007-08-01       Impact factor: 4.147

2.  Validation of the Distress Thermometer, Impact Thermometer and combinations of these in screening for distress.

Authors:  Donald McLaren Baken; Cheryl Woolley
Journal:  Psychooncology       Date:  2011-03-02       Impact factor: 3.894

3.  Reliability and validity of the Faces and Word Descriptor Scales to measure procedural pain.

Authors:  J F Keck; J E Gerkensmeyer; B A Joyce; J G Schade
Journal:  J Pediatr Nurs       Date:  1996-12       Impact factor: 2.145

4.  Screening for psychologic distress in ambulatory cancer patients.

Authors:  Paul B Jacobsen; Kristine A Donovan; Peter C Trask; Stewart B Fleishman; James Zabora; Frank Baker; Jimmie C Holland
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

5.  Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases.

Authors:  P Wolkenstein; J Zeller; J Revuz; E Ecosse; A Leplège
Journal:  Arch Dermatol       Date:  2001-11

6.  Psychiatric disorders in pediatric primary care. Prevalence and risk factors.

Authors:  E J Costello; A J Costello; C Edelbrock; B J Burns; M K Dulcan; D Brent; S Janiszewski
Journal:  Arch Gen Psychiatry       Date:  1988-12

7.  The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.

Authors:  V Mor; L Laliberte; J N Morris; M Wiemann
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

8.  Social, emotional, and behavioral functioning of children with NF1.

Authors:  Robert B Noll; Jennifer Reiter-Purtill; Bartlett D Moore; Elizabeth K Schorry; Anne M Lovell; Kathryn Vannatta; Cynthia A Gerhardt
Journal:  Am J Med Genet A       Date:  2007-10-01       Impact factor: 2.802

9.  Behavioral and emotional problems among preschool children in pediatric primary care: prevalence and pediatricians' recognition. Pediatric Practice Research Group.

Authors:  J V Lavigne; H J Binns; K K Christoffel; D Rosenbaum; R Arend; K Smith; J R Hayford; P A McGuire
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  7 in total

1.  Comparing Parent and Child Self-report Measures of the State-Trait Anxiety Inventory in Children and Adolescents with a Chronic Health Condition.

Authors:  Lindsey M Shain; Maryland Pao; Mary V Tipton; Sima Zadeh Bedoya; Sun J Kang; Lisa M Horowitz; Lori Wiener
Journal:  J Clin Psychol Med Settings       Date:  2020-03

2.  The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.

Authors:  Samira Foji; Eesa Mohammadi; Akram Sanagoo; Leila Jouybari
Journal:  Iran J Nurs Midwifery Res       Date:  2021-07-20

3.  Documentation of Psychosocial Distress and Its Antecedents in Children with Rare or Life-Limiting Chronic Conditions.

Authors:  Sarah R McCarthy; Elizabeth H Golembiewski; Derek L Gravholt; Jennifer E Clark; Jeannie Clark; Caree Fischer; Hannah Mulholland; Kristina Babcock; Victor M Montori; Amie Jones
Journal:  Children (Basel)       Date:  2022-05-05

4.  Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study.

Authors:  Xiaoqin Yang; Hyun Kyoo Yoo; Suvina Amin; Wendy Y Cheng; Sanjana Sundaresan; Lujia Zhang; Mei S Duh
Journal:  Neurol Ther       Date:  2022-06-09

5.  Using formative evaluation to plan for electronic psychosocial screening in pediatric oncology.

Authors:  Jordan Gilleland Marchak; Sean N Halpin; Cam Escoffery; Shadé Owolabi; Ann C Mertens; Karen Wasilewski-Masker
Journal:  Psychooncology       Date:  2020-10-20       Impact factor: 3.894

6.  Neurofibromatosis Type 1 with Massive Ventricular Polyposis: First Report in the Medical Literature.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Uwe Wollina; Torello Lotti; Georgi Konstantinov Maximov; Ilia Lozev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-01

7.  The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.

Authors:  Francesca Cervi; Veronica Saletti; Katherine Turner; Angela Peron; Sara Bulgheroni; Matilde Taddei; Francesca La Briola; Maria Paola Canevini; Aglaia Vignoli
Journal:  Orphanet J Rare Dis       Date:  2020-09-07       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.